Jialin Zheng - Selected Publications#

1. Tan F*, Li X, Wang Z, Li J, Shazard KA, and Zheng JC (2024). Clinical applications of stem cell-derived exosomes. Signal Transduction and Targeted Therapy. 2024 Jan 12;9(1):17. doi: 10.1038/s41392-023-01704-0.PMID: 38212307 (IF = 39.3)

2. Chen H, Fu S, Li X, Shi M, Qian J, Zhao S, Yuan P, Ding L, Xia X* and Zheng JC* (2023). Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages. Signal Transduction and Targeted Therapy. 2023 Dec 15;8(1):452. doi: 10.1038/s41392-023-01699-8.PMID: 38097558 (IF = 39.3)

3. Gao Gǂ, Li Cǂ, Ma Yǂ, Liang Zǂ, Li Y, Li X, Fu S, Wang Y*, Xia X*, Zheng JC*. Neural stem cell-derived extracellular vesicles mitigate Alzheimer's disease-like phenotypes in a preclinical mouse model. Signal Transduct Target Ther. 2023; 8(1):228. (IF=39.3)

4. Yuan Pǂ, Li Jǂ, Liu J, Liu H, Gong S, Wang L, Liu J, Li C, Wang Y, Xia X*, Zheng JC*. Cognitive dysfunction in patients with pulmonary hypertension. Am J Resp Crit Care. 2022; 206(10):1289-1293. (IF=24.7)

5. Xia X, Wang Y, Qin Y, Zhao S, Zheng JC*. Exosome: a novel neurotransmission modulator or non-canonical neurotransmitter. Ageing Res Rev. 2022; 74:101558.(IF=13.1)

6. Xia Xǂ*, Wang Yǂ, Zheng JC*. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative disease. Transl Neurodegener. 2022; 11:53.(IF=12.6)

7. Li Yǂ, Xia Xǂ*, Wang Y, Zheng JC*. Mitochondrial Dysfunction in Microglia: A Novel Perspective for Pathogenesis of Alzheimer's Disease. J Neuroinflamm. 2022; 19(1):248. (IF=9.3)

8. Ji Cǂ, Tang Yǂ, Zhang Y, Li C, Liang H, Ding L, Xia X, Xiong L, Qi X*, Zheng JC*. Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression. Brain Behav Immun. 2021; 99:231-245.(IF=15.1)

9. Wang Y, Li Y, Zhao R, Wu B, Lanoha B, Tong Z, Peer J, Liu J, Xiong H, Huang Y*, Zheng JC*. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice. Brain Behav Immun.2017; 66:135-145. (IF=15.1)

10. Lai S, Zhang M, Xu D, Zhang Y, Qiu L, Tian C*, Zheng JC*. Direct Reprogramming of Induced Neural Progenitors: A New Promising Strategy for Alzheimer’s diseases treatment. Transl Neurodegener. 2015; 4:7. (IF=12.6)